| Recruiting | Study to Evaluate the Safety and Efficacy of Larsucosterol in Participants With Alcohol-associated Hepatitis ( NCT07428538 | Bausch Health Americas, Inc. | Phase 3 |
| Recruiting | ePro Diary - HDV ( MACROLIVER ) NCT07442760 | FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS | — |
| Recruiting | Conventional Ultrasound Versus Remote Ultraportable ulTrasound in the Context of Viral Hepatitis NCT06571981 | Naik Vietti Violi | — |
| Recruiting | Low Dead-space Injecting Equipment Distribution Program for People Who Inject Drugs in Low- and Middle-income NCT06395129 | Médecins du Monde | — |
| Recruiting | Acute Hepatitis in Pediatrics NCT06761261 | IRCCS Azienda Ospedaliero-Universitaria di Bologna | — |
| Recruiting | The Safety ,Tolerability and Efficacy Study of HepaCure in Chinese Subjects with Acute-On-Chronic Liver Failur NCT05989958 | Hexaell Biotech Co., Ltd. | Phase 1 / Phase 2 |
| Unknown | The Living With a Long-Term Condition Study NCT06072287 | King's College London | — |
| Recruiting | To Evaluate the Efficacy and Safety of TYNADOTE® in the Treatment of Acetaminophen Overdose NCT05557448 | Sinew Pharma Inc. | Phase 2 |
| Unknown | Epidemiology of Occult Hepatitis C Virus Infection in Patients Born Before 1969 in the Hospital Setting: a Spo NCT05813691 | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | — |
| Unknown | Effectiveness of Ultrasound in Liver Stiffness and Fat Quantification NCT06111859 | King's College Hospital NHS Trust | N/A |
| Unknown | A Bidirectional Study in Exploring the Dynamic Changes of Plasma and Urine Metabolites of Liver Cancer NCT05719480 | Nanfang Hospital, Southern Medical University | — |
| Unknown | A Partial Randomized, Single-blind or Open-label, Dose-escalation With Multiple-dose Design Study to Evaluate NCT05563961 | Sinew Pharma Inc. | N/A |
| Unknown | Efficacy of N-acetylcysteine to Prevent Anti-tuberculosis Drug-induced Liver Injury: A Randomized Controlled T NCT05738681 | Mahidol University | Phase 2 / Phase 3 |
| Unknown | Evaluation of Orthohepevirus C Infection as an Emerging Cause of Zoonotic Origin Disease NCT05062967 | Maimónides Biomedical Research Institute of Córdoba | — |
| Recruiting | Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research Init NCT05635266 | Sanguine Biosciences | — |
| Completed | ECP for Immune-related Adverse Events After Checkpoint Inhibitor Treatment NCT05414552 | University of Freiburg | — |
| Unknown | Ursodeoxycholic Acid Combined With Total Glucosides of Paeony in the Treatment of PBC With AIH Features 1 NCT04618575 | West China Hospital | Phase 4 |
| Unknown | Recovering Damaged Cells for Sequelae Caused by COVID-19, SARS-CoV-2 NCT04846010 | All Natural Medicine Clinic, LLC | Phase 1 / Phase 2 |
| Completed | Does Hepatitis C Management Protect Egyptian Population Against Severe Corona Virus Disease-2019? NCT04757272 | Zagazig University | — |
| Unknown | Liver Toxicity in Lung Cancer Patients Treated With Immune-checkpoint Inhibitors. NCT04595734 | Western Sydney Local Health District | — |
| Unknown | Strategies for Hepatitis C Testing and Treatment in Aboriginal Communities That Lead to Elimination NCT03776760 | Kirby Institute | — |
| Completed | HEPLISAV-B Hepatitis B Vaccine in Chronic Lymphocytic Leukemia (CLL) and CLL Treated With Bruton's-Tyrosine Ki NCT03685708 | National Heart, Lung, and Blood Institute (NHLBI) | Phase 2 |
| Terminated | An Observational Study of Patients With Chronic Hepatitis B (CHB) Infection NCT03692897 | Target PharmaSolutions, Inc. | — |
| Completed | Crowdsourcing to Promote HBV and HCV Testing in China NCT03482388 | University of North Carolina, Chapel Hill | N/A |
| Completed | Vaccination Adjuved Against Hepatitis B in SNS Workers Typed as no Responders to Conventional Vaccines NCT03410953 | Fundación Instituto de Estudios de Ciencias de la Salud de Castilla y León | Phase 4 |
| Completed | Monitoring the IMmUological TOXicity of Drugs NCT03480529 | Groupe Hospitalier Pitie-Salpetriere | — |
| Completed | Addiction, HIV and Tuberculosis in Malaysian Criminal Justice Settings NCT03089983 | Yale University | N/A |
| Unknown | the Possible Effect of the Antiviral Inhibitors for Treatment of Hepatitis C Virus Infection in Cardiac Functi NCT03166943 | Assiut University | N/A |
| Unknown | Evaluation of Hepatic Fibrosis on Multiparametric MRI NCT03085342 | Seoul National University Hospital | N/A |
| Completed | A Randomized, Open-label, Single-dosing, 2X2 Crossover Study to Compare the Safety and Pharmacokinetics of BR- NCT02920931 | Boryung Pharmaceutical Co., Ltd | Phase 1 |
| Terminated | Efficacy and Safety of Grazoprevir (+) Uprifosbuvir (+) Ruzasvir (MK-3682B) (MK-5172 + MK-3682 + MK-8408) Fixe NCT02613403 | Merck Sharp & Dohme LLC | Phase 2 |
| Unknown | Safety and Immunogenicity of Recombinant Hepatitis B Vaccines in the Neonates NCT02764671 | Shenzhen Kangtai Biological Products Co., LTD | Phase 4 |
| Completed | Autologous Dendritic Cell Vaccine for Treatment of Patients With Chronic HCV-Infection NCT03119025 | Russian Academy of Medical Sciences | Phase 1 / Phase 2 |
| Unknown | Empowering Immigrants in the Greater Boston Area to Connect to HBV Care NCT02342821 | Massachusetts General Hospital | — |
| Completed | Comparative Assessment of Utilization of Antiviral Therapies in Hepatitis C and Effectiveness of Daclatasvir-c NCT02368522 | Bristol-Myers Squibb | — |
| Completed | The Curative Effect of Entecavir Combined Resveratrol on HBV patients-a Multi-center, Random, Open Clinical Tr NCT03509688 | The First Hospital of Jilin University | N/A |
| Suspended | Genomic Resources for Enhancing Available Therapies (GREAT1.0) Study NCT04306939 | University of Pittsburgh | — |
| Completed | Sofosbuvir-Containing Regimens Without Interferon For Treatment of Acute Hepatitis C Virus (HCV) Infection NCT02128217 | Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections | Phase 1 |
| Completed | Comorbidities and Virologic Outcome Among Patients on Anti-retroviral Therapy in Rural Lesotho NCT02126696 | Swiss Tropical & Public Health Institute | — |
| Unknown | TO Compare the Triple Drug Therapy and Dual Therapy . NCT02075242 | Asan Medical Center | Phase 4 |
| Unknown | Immune Cell Dysfunction in Severe Alcoholic Hepatitis NCT02275195 | Mid and South Essex NHS Foundation Trust | — |
| Completed | An Open-label Comparative Efficacy and Safety Study of Algeron (Cepeginterferon Alfa-2b) in Treatment-naive Pa NCT01889433 | Biocad | Phase 3 |
| Completed | An Open-label Randomized Multicenter Phase III Clinical Study Comparing Safety and Efficacy of Algeron (Cepegi NCT02103439 | Biocad | Phase 3 |
| Unknown | Using Entecavir to Reduce Hepatitis in Highly Viremic HBV Patients During Anti-tuberculous Treatment NCT01724723 | National Taiwan University Hospital | Phase 4 |
| Completed | Computer-based Cognitive Behavioral Therapy for Risky Behaviors in Opioid Dependent Patients NCT01645033 | Yale University | N/A |
| Completed | Identification of Specific Modulation Frequencies in Hepatitis B Carriers With and Without Hepatocellular Carc NCT01641276 | Hospital Sirio-Libanes | N/A |
| Completed | Algeron (Cepeginterferon Alfa-2b) Compared With PegIntron (Peginterferon Alfa-2b) for Treatment of Chronic Hep NCT01740089 | Biocad | Phase 2 / Phase 3 |
| Terminated | Boceprevir Drug Combination for Hepatitis C Treatment in People With and Without HIV NCT01443923 | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 4 |
| Unknown | Reintroduction Regimens After Hepatitis During Anti-tuberculosis Treatment NCT01395654 | National Taiwan University Hospital | Phase 4 |
| Completed | Rapid 10-Minute Liver MRI Protocol in Patients With Suspected Hepatocellular Carcinoma NCT01390194 | University of Nebraska | — |
| Completed | The Health Access and Recovery Peer Program NCT01725815 | Emory University | N/A |
| Completed | Anti-tuberculosis (TB) Drug Levels and Correlation With Drug Induced Hepatotoxicity NCT01456845 | All India Institute of Medical Sciences | — |
| Unknown | Patterns of Early Hepatitis C Virus Decline Predict the Outcome of Interferon Therapy NCT01434212 | The First Hospital of Jilin University | — |
| Unknown | Comparative Effectiveness of Web-based Versus Traditional Adolescent HIV Prevention NCT01142882 | National Development and Research Institutes, Inc. | N/A |
| Completed | HCV Epidemiological Survey in China Rural Area NCT04593355 | The First Hospital of Jilin University | — |
| Completed | Filibuvir In Treatment Naive Hepatitis C Virus (HCV) Genotype 1 Subjects NCT00987337 | Pfizer | Phase 2 |
| Completed | Role of Cytokines in Hepatitis E Virus Infection During Pregnancy NCT01062321 | Maulana Azad Medical College | — |
| Completed | Surveillance Study to Determine the Trends in Acute Hepatitis A Among Panamanian Children NCT01159925 | GlaxoSmithKline | — |
| Completed | ANRS HC20 Effectiveness of an Optimized Anti HCV PegIFN-alpha2a + Ribavirin on Sustained Virological Response NCT00901524 | ANRS, Emerging Infectious Diseases | Phase 2 |
| Completed | Epidemiological Study in Children and Adolescents With Chronic Hepatitis B NCT01163240 | Novartis Pharmaceuticals | — |
| Completed | Effectiveness of Hepatitis A Virus Vaccination Among Homosexual Males at Risk for Hepatitis A Infection NCT01102296 | National Taiwan University Hospital | N/A |
| Completed | The Efficacy and Safety of Pioglitazone in Patients With Nonalcoholic Steatohepatitis NCT01068444 | Kaohsiung Medical University Chung-Ho Memorial Hospital | Phase 2 |
| Unknown | A Single-Arm Study Evaluating the Efficacy of Liquid Acupuncture Therapeutics in Chronic Hepatitis B NCT00815464 | Yu Medical Garden | N/A |
| Completed | Analysis of Trends Over Time of Hepatitis Related Incidence in Panama NCT01159951 | GlaxoSmithKline | — |
| Completed | Telesonography Adaptation and Use to Improve the Standard of Patient Care Within a Dominican Community NCT00591968 | Edward Via Virginia College of Osteopathic Medicine | N/A |
| Completed | MRI to Measure Liver Fat Content NCT00594412 | National Institute of Allergy and Infectious Diseases (NIAID) | N/A |
| Completed | Investigation of the Effect of N Acetylcysteine Against Anti-Tuberculosis Drugs Induced Liver Toxicity NCT00564642 | National Research Institute of Tuberculosis and Lung Disease, Iran | N/A |
| Completed | Anti-tuberculosis (TB) Drug Levels and Hepatotoxicity NCT00929786 | All India Institute of Medical Sciences | — |
| Completed | Hepatitis B Virus Reactivation After Withdrawal of Prophylactic Antiviral Therapy in Lymphoma Patients NCT02108444 | Peking University | — |
| Completed | Evaluation the Growth Factors(IGF-1,IGFBP-3and HGH)in Patients With Chronic Liver Disease NCT00679692 | Kaohsiung Medical University Chung-Ho Memorial Hospital | — |
| Terminated | Protein Biomarker in Hepatocellular Carcinoma NCT00465842 | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | — |
| Completed | HEPMET-1: Evaluate the Feasibility, Mental Sideeffects and the Efficacy of Hepatitis C Treatment in a MMT Grou NCT00147784 | Sorlandet Hospital HF | Phase 3 |
| Completed | VaxTeen Hepatitis B Vaccine Booster Study NCT00144313 | Centers for Disease Control and Prevention | Phase 4 |
| Completed | The MARS® Albumin Dialysis System in Patients With Fulminant and Subfulminant Hepatic Failure NCT00224705 | Assistance Publique - Hôpitaux de Paris | Phase 3 |
| Completed | HIV-HCV Coinfection: Impact of Immune Dysfunction NCT00575315 | Virginia Commonwealth University | — |
| Completed | Merimepodib (MMPD) in Triple Combination for the Treatment of Chronic Hepatitis C NCT00088504 | Vertex Pharmaceuticals Incorporated | Phase 2 |
| Completed | S-Adenosylmethionine Therapy for Non-Alcoholic Steatohepatitis NCT00108589 | US Department of Veterans Affairs | Phase 3 |
| Completed | Telbivudine Versus Lamivudine in Adults With Decompensated Chronic Hepatitis B and Evidence of Cirrhosis NCT00076336 | Novartis Pharmaceuticals | Phase 3 |
| Completed | Safety and Efficacy Study of a Caspase Inhibitor in Patients Undergoing Liver Transplantation NCT00080236 | Conatus Pharmaceuticals Inc. | Phase 2 |
| Completed | Orlistat (Xenical) in the Treatment of Overweight Patients With Nonalcoholic Steatohepatitis (NASH) NCT00160407 | St. Louis University | Phase 4 |
| Completed | Efficacy of Silymarin for Acute Hepatitis NCT00412763 | University of Maryland, Baltimore | Phase 4 |
| Completed | Treating Nonalcoholic Steatohepatitis (NASH) With Metformin NCT00063232 | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Phase 2 |
| Completed | A Network & Dyad HIV Prevention Intervention for IDU's - 1 NCT00218335 | Johns Hopkins Bloomberg School of Public Health | Phase 2 |
| Completed | Treating Nonalcoholic Steatohepatitis With Pioglitazone NCT00062764 | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Phase 2 |
| Completed | Hepatitis C: Grading and Staging by MR NCT00059397 | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | — |
| Completed | Treatment of Acute Hepatitis C Virus Infection With Pegylated Interferon in Injection Drug Users NCT00194480 | National Institute on Drug Abuse (NIDA) | Phase 4 |
| Completed | PEG-Intron Plus Rebetol Treatment of Chronic Hepatitis C Subjects Who Failed Response to Alpha-Interferon Plus NCT00039871 | Merck Sharp & Dohme LLC | Phase 3 |
| Completed | Lamivudine and Adefovir to Treat Chronic Hepatitis B NCT00023309 | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Phase 2 |
| Completed | A Safety and Efficacy Study of the Hepatitis E Vaccine in Nepal. NCT00287469 | U.S. Army Medical Research and Development Command | Phase 2 |
| Completed | Twinrix Pregnancy Registry NCT03619590 | GlaxoSmithKline | — |
| Completed | Response to Booster Doses of Hepatitis B Vaccine in Children and Adolescents NCT00141999 | Centers for Disease Control and Prevention | — |
| Completed | Collections of Blood and Stool Samples in Patients With Acute Hepatitis NCT00001879 | National Heart, Lung, and Blood Institute (NHLBI) | — |
| Completed | Manhattan HIV/Hepatology Brain Bank NCT00300209 | Icahn School of Medicine at Mount Sinai | — |
| Completed | A Controlled Prospective Study of Transfusion-Associated Hepatitis NCT00004848 | National Institutes of Health Clinical Center (CC) | — |